| Financial Year |
March 31 2023 |
| Monetary Funds |
7,618,286,621.39 |
| Held-for-trading Financial Assets |
3,923,343,886.28 |
| Notes Receivable |
39,978,235.54 |
| Accounts Receivable |
177,720,385.37 |
| Advances to Suppliers |
77,878,497.42 |
| Other Receivables |
19,896,793.44 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
6,094,837,753.85 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,813,598,180.62 |
| Total Current Assets |
22,485,406,125.79 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
196,332,170.66 |
| Investment Properties |
-- |
| Fixed Assetes |
15,179,006,361.95 |
| Under-construction Projects |
2,681,724,135.49 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
337,477,412.62 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,299,140,773.37 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
57,336,825.76 |
| Deferred Income Tax Assets |
159,451,869.17 |
| Other Non-Current Assets |
39,406,082.50 |
| Sub-Total of Non-Current Assets |
20,370,908,886.88 |
| Total Assets |
42,856,315,012.67 |
| Short-Term Loans |
9,979,189,241.05 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
2,921,355,728.37 |
| Accounts Received In Advance |
1,362,918.78 |
| Employee Compensation Payable |
595,266,923.31 |
| Taxes Payable |
472,706,283.45 |
| Interest Payable |
-- |
| Dividend Payable |
20,715,979.73 |
| Other payables |
808,120,913.10 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
81,976,011.75 |
| Other Current Liabilities |
164,097,748.17 |
| Sub-Total of Current Liabilities |
18,442,224,035.60 |
| Long-term Loans |
11,830,370.70 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
252,887,085.61 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
725,966,759.00 |
| Total Liabilities |
19,168,190,794.60 |
| Paid-In Capital(Or Share Stock) |
3,464,661,213.00 |
| Capital Surplus |
8,062,645,939.40 |
| Surplus Reserve |
1,831,906,631.94 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
9,856,885,696.78 |
| Minority Stockholder's Interest |
346,976,980.18 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
23,341,147,237.89 |
| Owner's Equity（Stockholder's Equity） |
23,688,124,218.07 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
42,856,315,012.67 |
